Treat COVID-19, but Not Only COVID-19: Stroke Matters as Well

Petra Sedova1,2,3,4,5, Robert D Brown1, Tomas Bryndziar2,4,5

  • 1Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

Insights

During the COVID-19 pandemic, stroke admissions and recanalization treatments decreased despite a low COVID-19 burden. Public health campaigns are needed to encourage emergency care for stroke symptoms.

Area of Science:

  • Neurology
  • Public Health
  • Epidemiology

Background:

  • Studies indicated reduced hospitalizations for acute stroke and fewer recanalization treatments during the COVID-19 pandemic.
  • The first wave of COVID-19 saw a low burden of cases in Czech hospitals (peak 39 per million).

Purpose of the Study:

  • To analyze nationwide data on stroke admissions and management in the Czech Republic during the initial phase of the COVID-19 pandemic.
  • To compare stroke care metrics between the early pandemic period (March-May 2020) and pre-pandemic times (January-February 2020 and March-May 2019).

Main Methods:

  • Utilized the National Register of Reimbursed Health Services to assess volumes of subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), and ischemic stroke (IS) admissions.
  • Analyzed recanalization treatment volumes (intravenous thrombolysis [IVT] and mechanical thrombectomy [MT]) and stroke care quality data, including door-to-needle time (DNT), onset-to-door time (ODT), and stroke severity (NIHSS).

Main Results:

  • Stroke admissions decreased by 14% (p < 0.001), IS by 14% (p < 0.001), SAH by 15% (p = 0.07), and ICH by 7% (p = 0.17) in March-May 2020 compared to March-May 2019.
  • Volumes of IVT and MT decreased by 14% (p = 0.001) and 19% (p = 0.01), respectively, while the proportions of IS patients receiving these treatments remained unchanged.
  • Door-to-needle time (DNT) and onset-to-door time (ODT) showed no significant differences between the periods (24 vs. 25 min and 168 vs. 156 min, respectively).

Conclusions:

  • Despite a low COVID-19 burden and stable stroke service organization, stroke admissions and recanalization treatment volumes declined during the pandemic's first wave.
  • Public health communication is crucial to encourage individuals to seek immediate medical attention for stroke symptoms during health crises like the COVID-19 pandemic.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
54
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
98
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
4.2K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
71
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
305
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
68